相关实验视频
Updated: Jul 12, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
在2名患有自身逆性高胆固醇血症的患者中,在添加埃维纳库马布后,LDL-C目标的实现
Giuliana Germana Mombelli1, Chiara Pavanello2, Francesco Vicari1
1Dyslipidemia Center, Niguarda Hospital, Milan, Italy (Mombelli, Dr Pavanello, Vicari, Alberti, and Dr Sirtori).
Journal of clinical lipidology
|March 3, 2026
概括
埃维纳巴可显著降低LDL胆固醇在患有自身逆性胆固醇高血症 (ARH) 的患者,这是一个罕见的遗传疾病. 这种LDL受体独立治疗为管理高胆固醇和预防心血管疾病提供了有前途的新治疗方案.
科学领域:
- 遗传学和分子生物学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自体递归高胆固醇血症 (ARH) 是一种罕见的遗传疾病,由LDLRAP1基因变异引起,导致极高的LDL胆固醇 (LDL-C) 和早发性心血管疾病.
- 标准的降脂疗法,如他类药物,由于它们依赖于LDL受体 (LDL-R) 功能,通常在ARH中表现出有限的疗效.
研究的目的:
- 为了评估埃维纳库马布的疗效,一个LDL-R独立的药物,在患有自体逆性高胆固醇血症 (ARH) 的患者中.
- 评估埃维纳库马布在患有致病性LDLRAP1变异的个体中降低LDL-C的影响.
主要方法:
- 两名患者的病例报告被诊断出患有自体性衰退性高胆固醇血症 (ARH).
- 埃维纳库马布作为一种补充疗法,用于最大耐受水平的背景降脂治疗.
- 对长期的LDL-C水平和对治疗的反应进行了监测.
主要成果:
- 第一个患者经历了82%的降低LDL-C与evinacumab在其他疗法,包括PCSK9抑制剂的不充分反应后.
- 第二名患者实现了持续的73.8%的LDL-C降低,使PCSK9抑制剂的停用成为可能.
- 这两位患者都显示出LDL-C水平显著且具有临床意义的降低.
结论:
- 埃维纳库马布在患有自身逆性胆固醇高血清症 (ARH) 的患者中表现出明显的LDL-C降低作用.
- 这项研究支持埃维纳库马布作为一种有效的LDL受体独立治疗选择,用于管理ARH.
- 这些发现强调了埃维纳库马布在解决对传统治疗无反应的具有挑战性的高胆固醇血症病例方面的潜力.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipid Absorption
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

